Show simple item record

dc.contributor.authorKamarajah, S K
dc.contributor.authorMarkar, S R
dc.date.accessioned2024-04-16T15:17:07Z
dc.date.available2024-04-16T15:17:07Z
dc.date.issued2021-07-19
dc.identifier.citationKamarajah SK, Markar SR. Author response to: Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study. Br J Surg. 2021 Aug 19;108(8):e279. doi: 10.1093/bjs/znab154en_US
dc.identifier.issn0007-1323
dc.identifier.eissn1365-2168
dc.identifier.doi10.1093/bjs/znab154
dc.identifier.pmid34412120
dc.identifier.urihttp://hdl.handle.net/20.500.14200/4223
dc.description.abstractNo abstract availableen_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.urlhttps://academic.oup.com/bjsen_US
dc.subjectGeneticsen_US
dc.subjectGastroenterologyen_US
dc.subjectSurgeryen_US
dc.titleAuthor response to: neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study.en_US
dc.typeArticle
dc.source.journaltitleBritish Journal of Surgery
dc.source.volume108
dc.source.issue8
dc.source.beginpagee279
dc.source.endpage
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.contributor.trustauthorKamarajah, S K
dc.contributor.departmentSurgeryen_US
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record